文献速递冠心病

心肌血运重建试验的解读与反思

Myocardial Revascularization Trials.
PubMed 文献 · Circulation · 2018-01-01

本文综述了近期比较经皮冠状动脉介入与冠状动脉旁路移植术治疗左主干及多支冠状动脉病变的试验。作者提出,部分知识合成(尤其关于非糖尿病患者低解剖复杂度中经皮冠状动脉介入非劣效性的声称)可能受试验设计、基于经皮冠状动脉介入适用性的患者选择及终点优化影响。建议审慎解读现有证据,并协作设计未来临床试验。

要点

  • 经皮冠状动脉介入非劣效性声称可能受试验设计偏倚影响
  • 患者选择基于经皮冠状动脉介入适用性可能影响结果外推
  • 终点优化可能倾向于经皮冠状动脉介入而非冠状动脉旁路移植术

核心结论

  • 近期比较经皮冠状动脉介入与冠状动脉旁路移植术的试验中,部分知识合成可能受设计、选择及终点优化影响,需审慎解读。

研究设计与样本

  • 本文为综述,回顾近期比较经皮冠状动脉介入与冠状动脉旁路移植术治疗左主干及多支冠状动脉病变的试验。

主要发现

  • 经皮冠状动脉介入非劣效性声称(尤其非糖尿病低解剖复杂度患者)可能受试验设计、患者选择及终点优化影响。

临床怎么用

  • 临床应审慎解读现有证据,不盲目外推经皮冠状动脉介入非劣效性结论。
  • 未来临床试验建议采用协作设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article reviews the context and evidence of recent myocardial revascularization trials that compared percutaneous coronary intervention with coronary artery bypass grafting for the treatment of left main and multivessel coronary artery disease. We develop the rationale that some of the knowledge synthesis resulting from these trials, particularly with regard to the claimed noninferiority of percutaneous coronary intervention beyond nondiabetic patients with low anatomic complexity, may have been affected by trial design, patient selection based on suitability for percutaneous coronary intervention, and end point optimization favoring percutaneous coronary intervention over coronary artery bypass grafting. We provide recommendations that include holding a circumspect interpretation of the currently available evidence, as well as suggestions for the collaborative design and conduct of future clinical trials in this and other fields.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Ruel M, Falk V, Farkouh ME, et al. Myocardial Revascularization Trials. Circulation. 2018. PMID: 30566019. doi:10.1161/CIRCULATIONAHA.118.035970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。